EP1303281A4 - Methods of treatment - Google Patents

Methods of treatment

Info

Publication number
EP1303281A4
EP1303281A4 EP01927076A EP01927076A EP1303281A4 EP 1303281 A4 EP1303281 A4 EP 1303281A4 EP 01927076 A EP01927076 A EP 01927076A EP 01927076 A EP01927076 A EP 01927076A EP 1303281 A4 EP1303281 A4 EP 1303281A4
Authority
EP
European Patent Office
Prior art keywords
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01927076A
Other languages
German (de)
French (fr)
Other versions
EP1303281A1 (en
Inventor
Maxwell D Cummings
Robert W Marquis Jr
Yu Ru
Scott K Thompson
Daniel F Veber
Dennis S Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1303281A1 publication Critical patent/EP1303281A1/en
Publication of EP1303281A4 publication Critical patent/EP1303281A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP01927076A 2000-04-18 2001-04-17 Methods of treatment Withdrawn EP1303281A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19771700P 2000-04-18 2000-04-18
US197717P 2000-04-18
PCT/US2001/012386 WO2001078734A1 (en) 2000-04-18 2001-04-17 Methods of treatment

Publications (2)

Publication Number Publication Date
EP1303281A1 EP1303281A1 (en) 2003-04-23
EP1303281A4 true EP1303281A4 (en) 2006-02-15

Family

ID=22730469

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01927076A Withdrawn EP1303281A4 (en) 2000-04-18 2001-04-17 Methods of treatment

Country Status (5)

Country Link
EP (1) EP1303281A4 (en)
JP (1) JP2003531122A (en)
AU (1) AU2001253560A1 (en)
CO (1) CO5280093A1 (en)
WO (1) WO2001078734A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092563A2 (en) * 2001-05-17 2002-11-21 Smithkline Beecham Corporation Protease inhibitors
JP2006504719A (en) * 2002-10-08 2006-02-09 メルク フロスト カナダ アンド カンパニー 4-Amino-azepan-3-one compounds as cathepsin K inhibitors useful in the treatment of osteoporosis
EP2240491B1 (en) 2008-01-09 2015-07-15 Amura Therapeutics Limited TETRAHYDROFURO(2,3-b)PYRROL-3-ONE DERIVATIVES AS INHIBITORS OF CYSTEINE PROTEINASES

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034155A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034156A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034565A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034566A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034160A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034158A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034154A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001070232A1 (en) * 2000-03-21 2001-09-27 Smithkline Beecham Corporation Protease inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158986A4 (en) * 1998-12-23 2002-03-27 Smithkline Beecham Corp Protease inhibitors

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034155A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034156A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034565A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034566A2 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034160A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034158A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001034154A1 (en) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
WO2001070232A1 (en) * 2000-03-21 2001-09-27 Smithkline Beecham Corporation Protease inhibitors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHAPMAN HAROLD A JR ET AL: "The role of thiol proteases in tissue injury and remodeling", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 150, no. 6 PART 2, 1994, pages S155 - S159, XP009059181, ISSN: 1073-449X *
NAKAGAWA TERRY ET AL: "Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus", SCIENCE (WASHINGTON D C), vol. 280, no. 5362, 17 April 1998 (1998-04-17), pages 450 - 453, XP002360104, ISSN: 0036-8075 *
See also references of WO0178734A1 *

Also Published As

Publication number Publication date
CO5280093A1 (en) 2003-05-30
AU2001253560A1 (en) 2001-10-30
EP1303281A1 (en) 2003-04-23
JP2003531122A (en) 2003-10-21
WO2001078734A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
GB0014969D0 (en) Novel method of treatment
GB2393202B (en) Methods of well treatment
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
GB0028264D0 (en) Well treatment
GB0007193D0 (en) Treatment of movrmrnt disorders
GB0028269D0 (en) Well treatment
AU5464601A (en) Treatment of scale
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
AU5000001A (en) Treatment of vitiligo
GB0124124D0 (en) Methods of treatment
EP1389105A4 (en) Method of treatment
GB2360453B (en) Treatment of skin conditions
GB0112216D0 (en) Method of treatment
AU9402401A (en) Treatment of cancers
GB0008921D0 (en) Method of treatment
GB0026838D0 (en) Treatment method
GB0118892D0 (en) Method of treatment
GB0130763D0 (en) Treatment methods
EP1303281A4 (en) Methods of treatment
IL161630A0 (en) Methods of treating endometreosis
GB0031321D0 (en) Treatment
GB0014904D0 (en) Methods of treatment
GB0013928D0 (en) Methods of treatment
GB0002762D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021118

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 11/06 20060101ALI20051221BHEP

Ipc: A61P 35/04 20060101ALI20051221BHEP

Ipc: A61P 35/00 20060101ALI20051221BHEP

Ipc: A61K 31/44 20060101ALI20051221BHEP

Ipc: A61K 31/55 20060101AFI20011101BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20060104

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1056502

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060617